DE60132474D1 - Ein immunostimulierendes nukleotid und ein tocol enthaltende zusammensetzung - Google Patents
Ein immunostimulierendes nukleotid und ein tocol enthaltende zusammensetzungInfo
- Publication number
- DE60132474D1 DE60132474D1 DE60132474T DE60132474T DE60132474D1 DE 60132474 D1 DE60132474 D1 DE 60132474D1 DE 60132474 T DE60132474 T DE 60132474T DE 60132474 T DE60132474 T DE 60132474T DE 60132474 D1 DE60132474 D1 DE 60132474D1
- Authority
- DE
- Germany
- Prior art keywords
- present
- vaccines
- tocol
- adjuvant compositions
- containing composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- 230000003308 immunostimulating effect Effects 0.000 title abstract 2
- 239000002773 nucleotide Substances 0.000 title 1
- 239000002671 adjuvant Substances 0.000 abstract 4
- 229960005486 vaccine Drugs 0.000 abstract 4
- 238000000034 method Methods 0.000 abstract 2
- DFUSDJMZWQVQSF-XLGIIRLISA-N (2r)-2-methyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-ol Chemical compound OC1=CC=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 DFUSDJMZWQVQSF-XLGIIRLISA-N 0.000 abstract 1
- 108091034117 Oligonucleotide Proteins 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0025577 | 2000-10-18 | ||
GBGB0025577.8A GB0025577D0 (en) | 2000-10-18 | 2000-10-18 | Vaccine |
PCT/EP2001/011985 WO2002032454A1 (en) | 2000-10-18 | 2001-10-16 | Adjuvant composition comprising an immunostimulatory oligonucleotide and a tocol |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60132474D1 true DE60132474D1 (de) | 2008-03-06 |
DE60132474T2 DE60132474T2 (de) | 2009-01-15 |
Family
ID=9901557
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60132474T Expired - Lifetime DE60132474T2 (de) | 2000-10-18 | 2001-10-16 | Ein immunostimulierendes nukleotid und ein tocol enthaltende zusammensetzung |
Country Status (21)
Country | Link |
---|---|
US (1) | US20040047869A1 (de) |
EP (1) | EP1326639B1 (de) |
JP (1) | JP2004511529A (de) |
KR (1) | KR20030044016A (de) |
CN (1) | CN100346829C (de) |
AT (1) | ATE383872T1 (de) |
AU (2) | AU2002221689B2 (de) |
BR (1) | BR0114785A (de) |
CA (1) | CA2425310A1 (de) |
CZ (1) | CZ20031094A3 (de) |
DE (1) | DE60132474T2 (de) |
ES (1) | ES2299530T3 (de) |
GB (1) | GB0025577D0 (de) |
HU (1) | HUP0303720A3 (de) |
IL (1) | IL155283A0 (de) |
MX (1) | MXPA03003406A (de) |
NO (1) | NO20031646L (de) |
NZ (1) | NZ525321A (de) |
PL (1) | PL365322A1 (de) |
WO (1) | WO2002032454A1 (de) |
ZA (1) | ZA200302887B (de) |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6207646B1 (en) * | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
US20030026782A1 (en) * | 1995-02-07 | 2003-02-06 | Arthur M. Krieg | Immunomodulatory oligonucleotides |
EP0855184A1 (de) * | 1997-01-23 | 1998-07-29 | Grayson B. Dr. Lipford | Pharmazeutisches Präparat das ein Polynukleotid und ein Antigen enthält, insbesondere zur Impfung |
US6406705B1 (en) * | 1997-03-10 | 2002-06-18 | University Of Iowa Research Foundation | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
US6693086B1 (en) * | 1998-06-25 | 2004-02-17 | National Jewish Medical And Research Center | Systemic immune activation method using nucleic acid-lipid complexes |
US20030022854A1 (en) | 1998-06-25 | 2003-01-30 | Dow Steven W. | Vaccines using nucleic acid-lipid complexes |
ES2572834T3 (es) * | 1999-02-17 | 2016-06-02 | Csl Limited | Complejos inmunogénicos y métodos relacionados con los mismos |
KR100917101B1 (ko) * | 2000-08-04 | 2009-09-15 | 도요 보세키 가부시키가이샤 | 플렉시블 금속적층체 및 그 제조방법 |
EP1416986A4 (de) * | 2001-06-29 | 2005-12-14 | Becton Dickinson Co | Intradermale freisetzung von vakzinen und gentherapeutischen mitteln mit einer mikrokanüle |
US8834900B2 (en) * | 2001-08-17 | 2014-09-16 | University Of Iowa Research Foundation | Combination motif immune stimulatory oligonucleotides with improved activity |
GB0123580D0 (en) * | 2001-10-01 | 2001-11-21 | Glaxosmithkline Biolog Sa | Vaccine |
CA2388049A1 (en) | 2002-05-30 | 2003-11-30 | Immunotech S.A. | Immunostimulatory oligonucleotides and uses thereof |
US7807803B2 (en) * | 2002-07-03 | 2010-10-05 | Coley Pharmaceutical Group, Inc. | Nucleic acid compositions for stimulating immune responses |
US20040053880A1 (en) * | 2002-07-03 | 2004-03-18 | Coley Pharmaceutical Group, Inc. | Nucleic acid compositions for stimulating immune responses |
US7605138B2 (en) * | 2002-07-03 | 2009-10-20 | Coley Pharmaceutical Group, Inc. | Nucleic acid compositions for stimulating immune responses |
US7576066B2 (en) * | 2002-07-03 | 2009-08-18 | Coley Pharmaceutical Group, Inc. | Nucleic acid compositions for stimulating immune responses |
US7569553B2 (en) * | 2002-07-03 | 2009-08-04 | Coley Pharmaceutical Group, Inc. | Nucleic acid compositions for stimulating immune responses |
AU2003246674B2 (en) * | 2002-07-10 | 2008-08-14 | Intervet International B.V. | Immunogenic composition comprising a fusion protein and a saponin adjuvant |
PT2241325E (pt) * | 2002-10-29 | 2012-04-12 | Coley Pharm Gmbh | Utilização de oligonucleótidos cpg no tratamento de infecção com vírus da hepatite c |
EP1608403A2 (de) * | 2003-04-02 | 2005-12-28 | Coley Pharmaceutical Group, Ltd. | Immunostimulatorische nukleinsäure öl-in-wasser emulsionen zur topischen anwendung |
US20050013812A1 (en) * | 2003-07-14 | 2005-01-20 | Dow Steven W. | Vaccines using pattern recognition receptor-ligand:lipid complexes |
EP1663316A2 (de) * | 2003-09-25 | 2006-06-07 | Coley Pharmaceutical Group, Inc. | Nucleinsäure-lipophile konjugate |
TWI235440B (en) * | 2004-03-31 | 2005-07-01 | Advanced Semiconductor Eng | Method for making leadless semiconductor package |
WO2005102369A1 (ja) * | 2004-04-22 | 2005-11-03 | Dainippon Sumitomo Pharma Co., Ltd. | 細菌細胞壁骨格成分を含有する製剤 |
KR100958505B1 (ko) * | 2004-07-18 | 2010-05-17 | 씨에스엘 리미티드 | 면역자극 복합체 및 향상된 인터페론-감마 반응을 유도하기위한 올리고뉴클레오티드 제제 |
PT1861120T (pt) * | 2005-03-23 | 2016-08-18 | Glaxosmithkline Biologicals Sa | Utilização de um vírus influenza e de um adjuvante de emulsão óleo-em-água para induzir células t cd4 e/ou melhorar a resposta de células b de memória |
KR100740237B1 (ko) * | 2005-05-10 | 2007-07-18 | 아이진 주식회사 | 올리고뉴클레오타이드 및 비독성 다당체를 포함하는면역보조제 |
SG163583A1 (en) * | 2005-07-07 | 2010-08-30 | Coley Pharm Group Inc | Anti-ctla-4 antibody and cpg-motif-containing synthetic oligodeoxynucleotide combination therapy for cancer treatment |
US11707520B2 (en) | 2005-11-03 | 2023-07-25 | Seqirus UK Limited | Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture |
WO2007052059A2 (en) * | 2005-11-04 | 2007-05-10 | Novartis Vaccines And Diagnostics Srl | Changing th1/th2 balance in split influenza vaccines with adjuvants |
ES2420829T3 (es) | 2005-11-04 | 2013-08-27 | Novartis Vaccines And Diagnostics S.R.L. | Vacunas adyuvantadas con antígeno de no virión preparadas a partir de virus de la gripe cultivados en cultivo celular |
TWI457133B (zh) * | 2005-12-13 | 2014-10-21 | Glaxosmithkline Biolog Sa | 新穎組合物 |
MX2009000660A (es) | 2006-07-17 | 2009-04-08 | Glaxosmithkline Biolog Sa | Vacuna de influenza. |
AU2007280690C1 (en) | 2006-07-31 | 2012-08-23 | Curevac Gmbh | Nucleic acid of formula (I): GIXmGn, or (II): CIXmCn, in particular as an immune-stimulating agent/adjuvant |
DE102006035618A1 (de) * | 2006-07-31 | 2008-02-07 | Curevac Gmbh | Nukleinsäure der Formel (I): GlXmGn, insbesondere als immunstimulierendes Adjuvanz |
PL2486938T3 (pl) * | 2006-09-26 | 2018-08-31 | Infectious Disease Research Institute | Kompozycja szczepionki zawierająca syntetyczny adiuwant |
CN101517082B (zh) | 2006-09-27 | 2014-01-22 | 科勒制药有限责任公司 | 具有增强的免疫刺激活性的含疏水性T类似物的CpG寡聚核苷酸类似物 |
EA015817B1 (ru) * | 2006-10-12 | 2011-12-30 | Глаксосмитклайн Байолоджикалс С.А. | Иммуногенная композиция, содержащая адъювант в виде эмульсии "масло в воде" |
PE20090146A1 (es) | 2007-04-20 | 2009-03-23 | Glaxosmithkline Biolog Sa | Composicion inmunogenica contra el virus influenza |
WO2009030254A1 (en) | 2007-09-04 | 2009-03-12 | Curevac Gmbh | Complexes of rna and cationic peptides for transfection and for immunostimulation |
EP2548960B1 (de) | 2008-01-31 | 2018-01-31 | CureVac AG | Nukleinsäure der Formel (NuGIXmGnNv)a und Derivate davon als immunstimulierendes Mittel/Adjuvans |
DK2310046T3 (da) | 2008-06-27 | 2016-04-25 | Zoetis Services Llc | Hidtil ukendte adjuvanssammensætninger |
CA2733147A1 (en) * | 2008-08-06 | 2010-02-11 | Novartis Ag | Microparticles for use in immunogenic compositions |
WO2010037408A1 (en) | 2008-09-30 | 2010-04-08 | Curevac Gmbh | Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof |
CN102307590A (zh) | 2009-02-10 | 2012-01-04 | 诺华有限公司 | 具有减少量的角鲨烯的流感疫苗 |
US20110053829A1 (en) | 2009-09-03 | 2011-03-03 | Curevac Gmbh | Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids |
SG186706A1 (en) | 2010-07-30 | 2013-02-28 | Curevac Gmbh | Complexation of nucleic acids with disulfide-crosslinked cationic components for transfection and immunostimulation |
WO2013113326A1 (en) | 2012-01-31 | 2013-08-08 | Curevac Gmbh | Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen |
PL2850431T3 (pl) | 2012-05-16 | 2018-09-28 | Immune Design Corp. | Szczepionki przeciwko HSV-2 |
SG11201508092YA (en) | 2013-04-18 | 2015-10-29 | Immune Design Corp | Gla monotherapy for use in cancer treatment |
US9463198B2 (en) | 2013-06-04 | 2016-10-11 | Infectious Disease Research Institute | Compositions and methods for reducing or preventing metastasis |
AU2014310934B2 (en) | 2013-08-21 | 2019-09-12 | CureVac SE | Respiratory syncytial virus (RSV) vaccine |
CA3005608C (en) | 2013-09-19 | 2020-06-30 | Zoetis Services Llc | Water-in-oil emulsions comprising immunostimulatory oligonucleotides |
WO2015149944A2 (en) | 2014-04-01 | 2015-10-08 | Curevac Gmbh | Polymeric carrier cargo complex for use as an immunostimulating agent or as an adjuvant |
KR20170097116A (ko) | 2015-01-16 | 2017-08-25 | 조에티스 서비시즈 엘엘씨 | 구제역 백신 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0382271B1 (de) * | 1989-02-04 | 1994-12-21 | Akzo Nobel N.V. | Tocole als Impfstoffadjuvans |
GB9326253D0 (en) * | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
US6589940B1 (en) * | 1997-06-06 | 2003-07-08 | Dynavax Technologies Corporation | Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof |
CZ303515B6 (cs) * | 1999-04-19 | 2012-11-07 | Smithkline Beecham Biologicals S. A. | Adjuvantní prostredek |
-
2000
- 2000-10-18 GB GBGB0025577.8A patent/GB0025577D0/en not_active Ceased
-
2001
- 2001-10-16 CZ CZ20031094A patent/CZ20031094A3/cs unknown
- 2001-10-16 IL IL15528301A patent/IL155283A0/xx unknown
- 2001-10-16 PL PL01365322A patent/PL365322A1/xx unknown
- 2001-10-16 EP EP01987673A patent/EP1326639B1/de not_active Expired - Lifetime
- 2001-10-16 DE DE60132474T patent/DE60132474T2/de not_active Expired - Lifetime
- 2001-10-16 HU HU0303720A patent/HUP0303720A3/hu unknown
- 2001-10-16 ES ES01987673T patent/ES2299530T3/es not_active Expired - Lifetime
- 2001-10-16 MX MXPA03003406A patent/MXPA03003406A/es unknown
- 2001-10-16 CN CNB018206603A patent/CN100346829C/zh not_active Expired - Fee Related
- 2001-10-16 AU AU2002221689A patent/AU2002221689B2/en not_active Ceased
- 2001-10-16 AU AU2168902A patent/AU2168902A/xx active Pending
- 2001-10-16 AT AT01987673T patent/ATE383872T1/de not_active IP Right Cessation
- 2001-10-16 KR KR10-2003-7005466A patent/KR20030044016A/ko not_active Application Discontinuation
- 2001-10-16 NZ NZ525321A patent/NZ525321A/en unknown
- 2001-10-16 JP JP2002535691A patent/JP2004511529A/ja active Pending
- 2001-10-16 CA CA002425310A patent/CA2425310A1/en not_active Abandoned
- 2001-10-16 BR BR0114785-4A patent/BR0114785A/pt not_active Withdrawn
- 2001-10-16 WO PCT/EP2001/011985 patent/WO2002032454A1/en active IP Right Grant
- 2001-10-16 US US10/399,356 patent/US20040047869A1/en not_active Abandoned
-
2003
- 2003-04-10 NO NO20031646A patent/NO20031646L/no not_active Application Discontinuation
- 2003-04-11 ZA ZA200302887A patent/ZA200302887B/en unknown
Also Published As
Publication number | Publication date |
---|---|
US20040047869A1 (en) | 2004-03-11 |
EP1326639B1 (de) | 2008-01-16 |
MXPA03003406A (es) | 2005-01-25 |
AU2168902A (en) | 2002-04-29 |
ATE383872T1 (de) | 2008-02-15 |
ES2299530T3 (es) | 2008-06-01 |
NO20031646D0 (no) | 2003-04-10 |
CN100346829C (zh) | 2007-11-07 |
IL155283A0 (en) | 2003-11-23 |
HUP0303720A2 (hu) | 2004-03-29 |
DE60132474T2 (de) | 2009-01-15 |
EP1326639A1 (de) | 2003-07-16 |
CZ20031094A3 (cs) | 2003-09-17 |
NZ525321A (en) | 2004-06-25 |
BR0114785A (pt) | 2003-12-23 |
ZA200302887B (en) | 2004-07-12 |
GB0025577D0 (en) | 2000-12-06 |
CA2425310A1 (en) | 2002-04-25 |
WO2002032454A1 (en) | 2002-04-25 |
HUP0303720A3 (en) | 2004-11-29 |
PL365322A1 (en) | 2004-12-27 |
KR20030044016A (ko) | 2003-06-02 |
NO20031646L (no) | 2003-06-14 |
CN1481254A (zh) | 2004-03-10 |
AU2002221689B2 (en) | 2004-04-01 |
JP2004511529A (ja) | 2004-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60132474D1 (de) | Ein immunostimulierendes nukleotid und ein tocol enthaltende zusammensetzung | |
ATE276758T1 (de) | Adjuvans-zusammensetzung, enthaltend saponin und ein immunstimulatorisches oligonukleotid | |
MY137619A (en) | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions | |
MY129263A (en) | Vaccine composition | |
MXPA01011047A (es) | Secuencias genomicas de neisseria y metodos para su uso. | |
EP1728863A3 (de) | C-Klasse-Oligonukleotidanaloge mit verbesserter immunostimulatorischer Wirkung | |
HK1042425B (zh) | 增加含cg模體的寡核酸甘酸的奈瑟氏菌抗原的殺菌活動 | |
MX349481B (es) | Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica. | |
WO2007031319A8 (en) | Compositions comprising immunostimulatory rna oligonucleotides and methods for producing said rna oligonucleotides | |
MXPA01003557A (es) | Secuencias genomicas de neisseria y metodos para su uso. | |
WO2009060281A3 (en) | Immune stimulatory oligoribonucleotide analogs containing modified oligophosphate moieties | |
WO2005017130A3 (en) | Tumour cell lines nm-f9 (dsm acc2606) and nm-d4 (dsm acc2605), uses thereof | |
MY127452A (en) | Vaccines. | |
BRPI0408077A (pt) | composições e métodos para prevenção e tratamento de doenças relacionadas com endotoxina e condições | |
WO2005117956A3 (en) | Neisserial vaccines | |
WO2002030458A8 (en) | Yersinia adhesion protein as vaccine adjuvant | |
WO2004013166A3 (en) | S. aureus antigene |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |